Table 2.

Summary of Rh Peptides Stimulating MC From AIHA Patients In Vitro

Case No.Synthetic Rh D or Cc/Ee Peptides Stimulating Proliferation (SI > 3)
D-SpecificCc/Ee-SpecificCc/Ee and D Shared
6, 7, 10*, 11, 12, 13, 15, 16, 22, 23, 24, 25, 26, 30, 31, 32, 33, 34, 35, 40 36 3, 4, 8, 9, 37, 39 
Not tested 6, 10, 15*, 19, 23, 26 None 
19, 25, 31 12 1, 29* 
None 13* 
None 13 2* 
None Not tested 1, 3, 4, 5, 8, 14, 21, 29*, 38 
19, 22, 31 30, 32 28* 
None None None 
None None None 
Case No.Synthetic Rh D or Cc/Ee Peptides Stimulating Proliferation (SI > 3)
D-SpecificCc/Ee-SpecificCc/Ee and D Shared
6, 7, 10*, 11, 12, 13, 15, 16, 22, 23, 24, 25, 26, 30, 31, 32, 33, 34, 35, 40 36 3, 4, 8, 9, 37, 39 
Not tested 6, 10, 15*, 19, 23, 26 None 
19, 25, 31 12 1, 29* 
None 13* 
None 13 2* 
None Not tested 1, 3, 4, 5, 8, 14, 21, 29*, 38 
19, 22, 31 30, 32 28* 
None None None 
None None None 
*

Peptide eliciting greatest proliferation.

Patient died before the panel of D peptides was tested.

Close Modal

or Create an Account

Close Modal
Close Modal